Drugs / Fluzone Standard Dose Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01205581 Comparator | Sep 2010 → Aug 2013 | HIV infectious disease, cancer | St. Jude Children's Research Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone Standard Dose Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01205581 ↗ |
| Known as | Fluzone | “Fluzone, a standard-dose form of TIV” NCT01205581 ↗ |
| Modality | Vaccine | “Fluzone, a standard-dose form of TIV” NCT01205581 ↗ |